Opdivo 1 Vial 40 mg/4 ml
1 Vial — 40 mg/4 ml
Opdivo is a medication used to treat some types of cancer, including melanoma, lung cancer, kidney cancer, bladder cancer, and some types of head and neck cancer. It is also used to treat a type of blood cancer called classical Hodgkin lymphoma.
- Turkish packaging
- Active ingredient: Nivolumab
Opdivo (nivolumab) is a revolutionary cancer immunotherapy that works by helping your immune system recognize and target cancer cells. It works by blocking the activity of a protein called PD-1, which cancer cells use to hide from the immune system. By blocking PD-1, Opdivo unleashes the power of your immune system to help fight your cancer. This can lead to an overall survival benefit in many types of cancer. Opdivo is the first approved immunotherapy treatment for metastatic non-small cell lung cancer (NSCLC), advanced renal cell carcinoma (RCC), classical Hodgkin lymphoma (cHL), and a type of head and neck cancer (HNSCC). It is also approved for several other types of cancer, including melanoma, bladder cancer, and liver cancer, and is being studied in many others.
Opdivo is designed to target and destroy cancer cells without damaging healthy cells, providing an alternative to traditional chemotherapy. By using the power of your own immune system, Opdivo may be able to provide long-term cancer control and improved quality of life.